Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Browse
Companies
APR is a Swiss based R&D company offering innovative patent protected products for out-licensing as well as integrated and centrally managed R&D services on a contract basis. More
Leksir develops and markets original pharmaceuticals and brand generics in four therapeutic areas. More
Kalight is devoted to developing patents dealing with viral CNS conditions and seeking licensees and partnerships. Currently, it is marketing its patent for certain herpes neurological conditions. More
Foam products for Dermatology, Gynecology, Cosmetics, Wound Healing and more More
Is committed to building on success, and the continued in-licensing of products and technologies is an acknowledged strategic priority More
Anadis Limited is a biopharmaceutical research and development company specialising in innovative products containing antibodies and bioactive factors. More
Good Biotech Corporation (GBC) is a leading producer of industrial scale high-purity polyclonal IgY(-Fc) antibodies from duck egg yolk, offering a wide range of biotechnology applications. More
BioVex : Developing a new class of vaccines to treat and prevent cancer - OncoVEX and ImmunoVEX, and a functional genomics platform for gene determination in the nervous system - NeuroVEX More
Your selection
Browse By
- Industry sector
- Generics
- Nutrition
- OTC/Non-Prescription
- Pediatric
- Personal Care
- Prescription
- Therapeutic target
- Candida
- Cytomegalovirus
- Ebola virus
- Escherichia coli
- Haemophilus influenzae
- Hantavirus
- Helicobacter pylori
- Herpes simplex virus
- Human B19 parvovirus
- Human papilloma virus
- Parainfluenza virus (Type 3)
- Pertussis
- Respiratory syncytial virus RSV
- Rubella
- Salmonella
- Varicella-zoster
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us